GSH Modification as a Marker for Plasma Source and Biological Response Comparison to Plasma Treatment

• Main Authors: Pietro Ranieri, Hager Mohamed, Brayden Myers, Leah Dobossy, Keely Beyries, Duncan Trosan, Fred C. Krebs, Vandana Miller, Katharina Stapelmann
• Format: Article
• Language: English
• Published: MDPI AG 2020-03-01
• Series: Applied Sciences
• Subjects: cost-jet; nspdbd; atmospheric pressure plasmas; low-temperature plasmas; plasma chemistry
• Online Access: https://www.mdpi.com/2076-3417/10/6/2025

This study investigated the use of glutathione as a marker to establish a correlation between plasma parameters and the resultant liquid chemistry from two distinct sources to predefined biological outcomes. Two different plasma sources were operated at parameters that resulted in similar biological responses: cell viability, mitochondrial activity, and the cell surface display of calreticulin. Specific glutathione modifications appeared to be associated with biological responses elicited by plasma. These modifications were more pronounced with increased treatment time for the European Cooperation in Science and Technology Reference Microplasma Jet (COST-Jet) and increased frequency for the dielectric barrier discharge and were correlated with more potent biological responses. No correlations were found when cells or glutathione were exposed to exogenously added long-lived species alone. This implied that short-lived species and other plasma components were required for the induction of cellular responses, as well as glutathione modifications. These results showed that comparisons of medical plasma sources could not rely on measurements of long-lived chemical species; rather, modifications of biomolecules (such as glutathione) might be better predictors of cellular responses to plasma exposure.